ERBB2 and cancer: Interestingly, PDCD1 (encoding programmed cell death protein 1), which is considered an immune-inhibitory receptor (18) and provides a new and reliable direction for cancer immunotherapy (19), was also frequently affected by CNAs in HER2-low TNBC samples (Figure 2A).